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established alternative to open repair for patients with
juxtarenal or short-neck AAAs.1e3 While computed tomog-
raphy angiography (CTA) is considered the gold standard for
surveillance, it bears the risk of contrast nephropathy and
exposure to ionizing radiation, and is associated with high
cost and resource allocation. Recommendations for stan-
dard EVAR have progressively changed to accept Duplex
ultrasound (DUS)-based strategies, at least for patients at
lower risk of complications. Currently, there are no speciﬁc
recommendations from scientiﬁc societies regarding fEVAR
surveillance, but expert opinion suggests close surveillance
is necessary to insure lasting results.1,2
Gargiulo et al.4 addressed the issue of surveillance after
fEVAR in a retrospective study comparing CTA and four-
dimensional contrast-enhanced ultrasound (4D-CEUS). The
authors suggest that 4D-CEUS is as accurate as CTA for
detecting diameter and volume changes, endoleaks, and
revascularized visceral vessel patency.While the conclusions
are interesting, these data must be analyzed with caution.
In fact, endoleak detection may be sub-optimal, as one in
three endoleaks were not detected with CEUS. A sample of
22 patients is clearly underpowered to obtain conclusions
that may inﬂuence clinical practice. It may be possible that,
due to the relative rarity of fEVAR, one may never obtain
enough power for robust conclusions.
Also, the added value of 4D (compared to “standard”
CEUS) appears only pertinent for volumetric measurements.
While this is a valuable research tool, it is not regularly used
in clinical practice and may have very limited inﬂuence on
the course of treatment.5 As such, the present study does
not add signiﬁcantly to the larger study by Perini et al.,6
where CEUS was compared favorably to CTA.
Lastly, DUS and CEUS have important limitations that
limit its applicability. These are largely related to access toDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.025
* F.B. Gonçalves, Erasmus University Medical Centre, Rotterdam,
’s-Gravendijkwal 230 3015 CE Rotterdam, The Netherlands.
E-mail address: f.bastosgoncalves@erasmusmc.nl (F. Bastos Gonçalves).
1078-5884/$ e see front matter  2014 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2014.08.001technology, operator-dependency and anatomical restrains
(temporary like bowel gas interposition, or permanent like
obesity as the authors rightfully point out). A frequently
disparaged aspect is that DUS-based surveillance limits the
possibility of pre-emptive treatment, or treatment before a
complication actually occurs. Migration, component
disconnection, and material fatigue are generally unrecog-
nized with DUS until they result in endoleak, rupture, or
occlusion. For fEVAR this may be especially true, given the
complexity of the procedure and higher chance of compli-
cations, particularly regarding vascularized visceral ves-
sels.1,3,7 The latter were not directly visualized with CEUS in
8% of patients in the present study.
Current evidence suggests that it is wise to individualize
surveillance after EVAR according to the patient’s life ex-
pectancy and renal function, and adapt the strategy ac-
cording to postoperative evolution. Despite these promising
results, CEUS (or 4D-CEUS) still seems a second-best mo-
dality, best suited for patients who have impaired renal
function or favorable aneurysm regression and evidence of
graft stability over time. As for standard EVAR, common
sense suggests that tailoring the intensity of surveillance to
individual patient risk, whatever the chosen image modality,
may be the preferred strategy.REFERENCES
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